Structure Therapeutics, Inc.
Structure Therapeutics is a public, clinical-stage biopharmaceutical company developing oral small-molecule drugs for chronic metabolic, cardiovascular, and pulmonary diseases, often targeting GPCRs. It uses structure-based and computational drug discovery to build a wholly owned pipeline. Founded in 2017 and headquartered in South San Francisco with offices in Shanghai, the company completed an IPO on Nasdaq (ticker: GPCR) in February 2023.
Open Positions at Structure Therapeutics, Inc.
1 open position
The AI Security Engineer will secure Structure Therapeutics’ AWS-based AI/ML platform, protecting models, data pipelines, and cloud infrastructure from emerging threats. The role combines hands-on cloud and AI security engineering with governance, incident response, and cross-functional collaboration.